(55 days)
Not Found
No
The 510(k) summary describes a mechanical implant system for spinal fixation and does not mention any software, algorithms, or AI/ML capabilities.
Yes
The device is described as an Anterior Cervical Plate System intended for screw fixation of the cervical spine to treat various medical conditions like degenerative disc disease, trauma, and tumors. This description clearly indicates a therapeutic purpose.
No
Explanation: The Sintea Biotech Anterior Cervical Plate System is described as a system of plates, screws, and instruments intended for anterior screw fixation of the cervical spine. It is a surgical implant used to provide structural support and is not used to diagnose a medical condition.
No
The device description clearly states it is a system of anterior cervical spine locking plates, screws, and associated instruments, all made of titanium alloy, indicating it is a hardware-based medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The Sintea Biotech Anterior Cervical Plate System is a surgical implant (plates, screws, and instruments) used for anterior screw fixation of the cervical spine. It is a physical device implanted in the body, not a test performed on a sample outside the body.
- Intended Use: The intended use is for surgical fixation of the cervical spine for various conditions, not for diagnostic testing of biological samples.
Therefore, this device falls under the category of a surgical implant or medical device, not an in vitro diagnostic.
N/A
Intended Use / Indications for Use
The Sintea Biotech Anterior Cervical Plate System is intended for anterior screw fixation of the cervical spine (C3 to C7).
The device is intended for single use only and is packaged non-sterile with sterilization required prior to use.
WARNING: This device is not intended for screw attachment or fixation to the posterior elements (pedicles) of the cervical, thoracic or lumbar spine.
The Sintea Biotech Anterior Cervical Plate System is indicated for use in the cervical spine (levels C3 to C7) in the following conditions:
- Degenerative disc disease (defined as neck pain of discogenic origin with . degeneration of the disc confirmed by history and radiographic studies)
- Spondylolisthesis
- Trauma (fracture or dislocation)
- Spinal stenosis
- Deformities or curvature (scoliosis, kyphosis, lordosis)
- Tumor
- Pseudarthrosis
- Failed previous fusion
Product codes
KWO
Device Description
The Sintea Biotech Anterior Cervical Plate System is a family of anterior cervical spine locking plates, screws and associated instruments, providing an anterior buttress. opstruct for use following Corpectomy or discectomy. Fixation is provided by bone screws inserted into the vertebral body of the cervical spine using an anterior approach. It is indicated for traumatic, degenerative, and tumor pathologies.
All system components are made of biocompatible Ti6A14V ELI titanium alloy, which minimizes the possibility of allergic reaction and enhances post-operative MRJ/CT analyses as described by ASTM F136. Do not use any of the Sintea Biotech Anterior Cervical Plate System components with components from any other system or manufacturer.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cervical spine (C3 to C7)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Fatigue testing of a worst case system configuration using constructs made of titanium alloy was conducted. The testing demonstrates that when subjected to repeated physiological loads, increased by suitable safety factors, the Sintea Biotech Anterior Cervical Plate System overcomes both static and fatigue tests, with occurrences of neither microscopic nor macroscopic failures, after five million cycles of repeated applied force, according to the ASTM F1717 test standard. Furthermore, testing of the worst case construct shows that the Sintea Biotech Anterior Cervical Plate System performs comparably with the Synthes CSLP predicate device in mechanical tests.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3060 Spinal intervertebral body fixation orthosis.
(a)
Identification. A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.(b)
Classification. Class II.
0
510(k) SUMMARY
KO4989
Sintea Biotech Anterior Cervical Plate System
Trade Name: Sintea Biotech Anterior Cervical Plate System Common Name: Anterior Cervical Plate System Classification Name(s): Appliance, Fixation, Spinal Intervertebral Body Spinal Fixation Device System Class II; Classification(s): § 888.3060 -- Spinal Intervertebral Body Fixation Orthosis Device Class: Class II for all requested indications Classification Panel: Orthopedic Device Panel Product Code(s): KWO
Applicant Name and Address:
Sintea Biotech, Inc. 407 Lincoln Road, Suite 10L Miami Beach, FL 33139 (305) 673-6226 FAX (305) 673-3312
Company Contact: Ms. Marcela Velazquez Sintea Biotech, Inc. 407 Lincoln Road, Suite 10L Miami Beach, FL 33139 (305) 673-6226 FAX (305) 673-3312
Performance Standards
Food and Drug Administration mandated Performance Standards for Spinal Intervertebral Body Fixation Device System Class II devices are not in effect. Sintea Biotech, Inc. intends to comply with all voluntary Performance Standards applicable to the Sinteal, and Biotech Anterior Cervical Plate System. At the present time, various performance standards such as ASTM, ISO, QSR/cGMP and in-house SOP standards are used. Sintea Biotech, Inc. also complies with the general controls authorized under Sections 501, 502, 510, 516, 519, and 520 of the Food, Drug and Cosmetic Act. In additions 301, 3 Biotech, Sr!., which is the location of the manufacturing facility for this device, has earned the CE Mark (number 0546) using the ISO 9001 quality system model, and the Medical Device Directive, and is in good standing with IQNet, their notified body. A declaration of conformity with design controls is also included in this 510(k) submission, signed by the manufacturer, Sintea Biotech, Srl.
Special Controls
Anterior Cervical Plate Systems must comply with the following special controls:
- Compliance with materials standards .
1
- Compliance with mechanical testing standards .
- Compliance with biocompatibility standards, and .
- Labeling which contains the following statements in addition to other appropriate . labeling information:
WARNING: This device is intended for anterior cervical intervertebral body fusions only.
WARNING: This device is not approved for screw attachments to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.
Labeling:
The Sintea Biotech Anterior Cervical Plate System discussed in this premarket notification will be manufactured by Sintea Biotech, and will be labeled as sprch. The system will be marketed exclusively to healthcare facilities and physicians. In addition, FDA requirements stipulate that the following additional labeling varnings be provided, as noted above:
Warnings:
WARNING: This device is intended for anterior cervical intervertebral body fusions only.
WARNING: This device is not approved for screw attachments to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Surgical Technique:
The surgical approach of the Sintea Biotech Anterior Cervical Plate System is enclosed in Section 8 of this submission, and includes this caution statement:
CAUTION: The Sintea Biotech Anterior Cervical Plate System is made of biocompatible Ti6A14V ELI titanium alloy. Mixing of dissimilar metals can accelerate the corrosion process. The components of this system must NOT be used with verblants of other metals in building a construct. Components of the Sintea Biotech Ann Inne Cervical Plate System should NOT be used with components from any other system or manufacturer.
Predicate Devices (legally marketed comparison devices):
Sintea Biotech, Inc. believes that the Sintea Biotech Anterior Cervical Plate System is substantially equivalent to Synthes' Cervical Spine Locking Plate (CSLP), K000742 and K000536, (Decision Dates: 03/29/2000 and 03/15/2000, respectively). A basic feature comparison table for the Sintea Biotech Anterior Cervical Plate System and this predicate device is located at the end of this section of the submission.
2
Device Description:
The Sintea Biotech Anterior Cervical Plate System is a family of anterior cervical spine locking plates, screws and associated instruments, providing an anterior buttress. opstruct for use following Corpectomy or discectomy. Fixation is provided by bone screws inserted into the vertebral body of the cervical spine using an anterior approach. It is indicated for traumatic, degenerative, and tumor pathologies.
All system components are made of biocompatible Ti6A14V ELI titanium alloy, which minimizes the possibility of allergic reaction and enhances post-operative MRJ/CT analyses as described by ASTM F136. Do not use any of the Sintea Biotech Anterior Cervical Plate System components with components from any other system or manufacturer.
Intended Use:
The Sintea Biotech Anterior Cervical Plate System is intended for anterior screw fixation of the cervical spine (C3 to C7).
The device is intended for single use only and is packaged non-sterile with sterilization required prior to use.
WARNING: This device is not intended for screw attachment or fixation to the posterior elements (pedicles) of the cervical, thoracic or lumbar spine.
Indications for Use:
The Sintea Biotech Anterior Cervical Plate System is indicated for use in the cervical spine (levels C3 to C7) in the following conditions:
- Degenerative disc disease (defined as neck pain of discogenic origin with . degeneration of the disc confirmed by history and radiographic studies)
- � Spondylolisthesis
- . Trauma (fracture or dislocation)
- . Spinal stenosis
- Deformities or curvature (scoliosis, kyphosis, lordosis) .
- . Tumor
- . Pseudarthrosis
- Failed previous fusion .
Summary of Biomechanical Testing:
Fatigue testing of a worst case system configuration using constructs made of titanium alloy was conducted. The testing demonstrates that when subjected to repeated physiological loads, increased by suitable safety factors, the Sintea Biotech And
3
Cervical Plate System overcomes both static and fatigue tests, with occurrences of neither microscopic nor macroscopic failures, after five million cycles of repeated applied force, according to the ASTM F1717 test standard. Furthermore, testing of the worst case construct shows that the Sintea Biotech Anterior Cervical Plate System performs comparably with the Synthes CSLP predicate device in mechanical tests.
Summary Basis for Equivalency and Comparison Table:
Mechanical tests of the Sintea Biotech Anterior Cervical Plate System demonstrate that the device is safe and effective for its intended use, and is substantially equivalents the predicate device (Synthes Spine's CSLP Cervical Spine Locking Plate). The favorable clinical performance of Synthes' CSLP provides additional confirmation that the Sintea Biotech Anterior Cervical Plate System is safe and effective for its intended use. The Sintea Biotech Anterior Cervical Plate System and the referenced predicate devices are similar in that:
- The devices have the same intended use and indications for use. .
- The devices are manufactured from the same material. .
- The mode of fixation of the devices is similar. .
- The devices have similar form, function, components, instruments, geometry, . dimensions, features and packaging.
- The devices have the same labeling and sterilization method. .
- The devices perform comparably in mechanical tests. .
The use of QSR-based process design controls, process controls, testing standards, material standards and similarities to the predicate device establish that the Sintea Biotech Anterior Cervical Plate System is substantially equivalent to Synthes Spine's CSLP, and that it is safe and effective for its intended use.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol of an eagle or bird-like figure with three stylized wings or feathers.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 1 6 2004
Isabella Elias Regulatory Affairs Associate Sintea Biotech, Inc. 407 Lincoln Road, Suite 10L Miami Beach, Florida 33139
Re: K041989
Trade/Device Name: Anterior Cervical Plate System Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal intervertebral body fixation orthosis Regulatory Class: II Product Code: KWO Dated: July 10, 2004 Received: July 23, 2004
Dear Ms. Elias:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
Page 2 - Isabella Elias
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4692. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Miriam C. Provost
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): N/A
Device Name: Sintea Biotech Anterior Cervical Plate System
Indications For Use: The Sintea Biotech Anterior Cervical Plate System is indicated for use in the cervical spine (levels C3 to C7) in the following conditions:
- Degenerative disc disease (defined as neck pain of discogenic origin with . degeneration of the disc confirmed by history and radiographic studies)
- Spondylolisthesis �
- Trauma (fracture or dislocation) .
- Spinal stenosis .
- Deformities or curvature (scoliosis, kyphosis, lordosis) .
- Tumor .
- Pseudarthrosis .
- Failed previous fusion .
AND/OR Over-The-Counter Use -------------------------------------------Prescription Use __X (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of
Miriam C. Provost
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
510(k) Number_ Ko4 1989_______________________________________________________________________________________________________________________________________________________